Ahmed Mohamed Aboelnaga

Ahmed Mohamed Aboelnaga

Auto-generated profile, based on publicly available information

Ahmed Mohamed Aboelnaga

Department of surgery, fuculty of medicine, suez canal university

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Burns
Verified
Journal Article
Closed access
AAAhmed Aboelnaga
Ahmed Aboelnaga
MEMoustafa Elmasry
Moustafa Elmasry
OAOsama A. Adly
Osama A. Adly
MEMohamed A. Elbadawy
Mohamed A. Elbadawy
AAAshraf H. Abbas
Ashraf H. Abbas
ISIngrid Steinvall
Ingrid Steinvall

12 December 2023 in Zagazig University Medical Journal
Verified
Journal Article
Open access
AGAmr Abdallah Gomaa
Amr Abdallah Gomaa
MEMohamed Abdelmoaty Elbadawy
Mohamed Abdelmoaty Elbadawy
MAMoaz Fathy Abbady
Moaz Fathy Abbady
AAAhmed Mohamed Aboelnaga
Ahmed Mohamed Aboelnaga
Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid.